• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G filed by Alignment Healthcare Inc.

    2/14/22 5:11:29 PM ET
    $ALHC
    Medical Specialities
    Health Care
    Get the next $ALHC alert in real time by email
    SC 13G 1 eh220225237_13g-ahi.htm SCHEDULE 13G

     

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

     

    SCHEDULE 13G

     

    Under the Securities Exchange Act of 1934

     

    (Amendment No. __)*

     

    Alignment Healthcare, Inc.

    (Name of Issuer)
     

    Class A common stock, par value $0.001 per share

    (Title of Class of Securities)
     

    01625V104

    (CUSIP Number)
     
    December 31, 2021
    (Date of Event which Requires Filing of this Statement)

     

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

     

      ☐ Rule 13d-1(b)
      ☐ Rule 13d-1(c)
      ☒ Rule 13d-1(d)

     

    *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

     

    The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

     

     

       

     

     

    CUSIP No. 01625V104 SCHEDULE 13G Page 2 of 22

     

     

    1

    NAME OF REPORTING PERSON

     

    Warburg Pincus Private Equity XII, L.P.

     
    2

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

     

     

    (a)  ☐

    (b)  ☒

    3

    SEC USE ONLY

     

     

     
    4

    CITIZENSHIP OR PLACE OF ORGANIZATION

     

    Delaware

     

    NUMBER OF

    SHARES

    BENEFICIALLY OWNED

    BY EACH REPORTING

    PERSON

    WITH

    5

    SOLE VOTING POWER

     

    0

    6

    SHARED VOTING POWER

     

    14,665,604

    7

    SOLE DISPOSITIVE POWER

     

    0

    8

    SHARED DISPOSITIVE POWER

     

    14,665,604

    9

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    14,665,604

     
    10

    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

     

     

    ☐
    11

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     

    7.8%

     
    12

    TYPE OF REPORTING PERSON

     

    PN

     

     

       

     

     

    CUSIP No. 01625V104 SCHEDULE 13G Page 3 of 22

     

     

    1

    NAME OF REPORTING PERSON

     

    Warburg Pincus Private Equity XII-B, L.P.

     
    2

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

     

     

    (a)  ☐

    (b)  ☒

    3

    SEC USE ONLY

     

     

     
    4

    CITIZENSHIP OR PLACE OF ORGANIZATION

     

    Delaware

     

    NUMBER OF

    SHARES

    BENEFICIALLY OWNED

    BY EACH REPORTING

    PERSON

    WITH

    5

    SOLE VOTING POWER

     

    0

    6

    SHARED VOTING POWER

     

    2,942,410

    7

    SOLE DISPOSITIVE POWER

     

    0

    8

    SHARED DISPOSITIVE POWER

     

    2,942,410

    9

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    2,942,410

     
    10

    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

     

     

    ☐
    11

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     

    1.6%

     
    12

    TYPE OF REPORTING PERSON

     

    PN

     

     

       

     

     

    CUSIP No. 01625V104 SCHEDULE 13G Page 4 of 22

     

     

    1

    NAME OF REPORTING PERSON

     

    Warburg Pincus Private Equity XII-D, L.P.

     
    2

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

     

     

    (a)  ☐

    (b)  ☒

    3

    SEC USE ONLY

     

     

     
    4

    CITIZENSHIP OR PLACE OF ORGANIZATION

     

    Delaware

     

    NUMBER OF

    SHARES

    BENEFICIALLY OWNED

    BY EACH REPORTING

    PERSON

    WITH

    5

    SOLE VOTING POWER

     

    0

    6

    SHARED VOTING POWER

     

    423,271

    7

    SOLE DISPOSITIVE POWER

     

    0

    8

    SHARED DISPOSITIVE POWER

     

    423,271

    9

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    423,271

     
    10

    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

     

     

    ☐
    11

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     

    0.2%

     
    12

    TYPE OF REPORTING PERSON

     

    PN

     

     

       

     

     

    CUSIP No. 01625V104 SCHEDULE 13G Page 5 of 22

     

     

    1

    NAME OF REPORTING PERSON

     

    Warburg Pincus Private Equity XII-E, L.P.

     
    2

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

     

     

    (a)  ☐

    (b)  ☒

    3

    SEC USE ONLY

     

     

     
    4

    CITIZENSHIP OR PLACE OF ORGANIZATION

     

    Delaware

     

    NUMBER OF

    SHARES

    BENEFICIALLY OWNED

    BY EACH REPORTING

    PERSON

    WITH

    5

    SOLE VOTING POWER

     

    0

    6

    SHARED VOTING POWER

     

    2,415,767

    7

    SOLE DISPOSITIVE POWER

     

    0

    8

    SHARED DISPOSITIVE POWER

     

    2,415,767

    9

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    2,415,767

     
    10

    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

     

     

    ☐
    11

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     

    1.3%

     
    12

    TYPE OF REPORTING PERSON

     

    PN

     

     

       

     

     

    CUSIP No. 01625V104 SCHEDULE 13G Page 6 of 22

     

     

    1

    NAME OF REPORTING PERSON

     

    WP XII Partners, L.P.

     
    2

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

     

     

    (a)  ☐

    (b)  ☒

    3

    SEC USE ONLY

     

     

     
    4

    CITIZENSHIP OR PLACE OF ORGANIZATION

     

    Delaware

     

    NUMBER OF

    SHARES

    BENEFICIALLY OWNED

    BY EACH REPORTING

    PERSON

    WITH

    5

    SOLE VOTING POWER

     

    0

    6

    SHARED VOTING POWER

     

    791,215

    7

    SOLE DISPOSITIVE POWER

     

    0

    8

    SHARED DISPOSITIVE POWER

     

    791,215

    9

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    791,215

     
    10

    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

     

     

    ☐
    11

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     

    0.4%

     
    12

    TYPE OF REPORTING PERSON

     

    PN

     

     

       

     

     

    CUSIP No. 01625V104 SCHEDULE 13G Page 7 of 22

     

     

    1

    NAME OF REPORTING PERSON

     

    Warburg Pincus XII Partners, L.P.

     
    2

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

     

     

    (a)  ☐

    (b)  ☒

    3

    SEC USE ONLY

     

     

     
    4

    CITIZENSHIP OR PLACE OF ORGANIZATION

     

    Delaware

     

    NUMBER OF

    SHARES

    BENEFICIALLY OWNED

    BY EACH REPORTING

    PERSON

    WITH

    5

    SOLE VOTING POWER

     

    0

    6

    SHARED VOTING POWER

     

    1,530,518

    7

    SOLE DISPOSITIVE POWER

     

    0

    8

    SHARED DISPOSITIVE POWER

     

    1,530,518

    9

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    1,530,518

     
    10

    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

     

     

    ☐
    11

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     

    0.8%

     
    12

    TYPE OF REPORTING PERSON

     

    PN

     

     

       

     

     

    CUSIP No. 01625V104 SCHEDULE 13G Page 8 of 22

     

     

    1

    NAME OF REPORTING PERSON

     

    Warburg Pincus LLC

     
    2

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

     

     

    (a)  ☐

    (b)  ☒

    3

    SEC USE ONLY

     

     

     
    4

    CITIZENSHIP OR PLACE OF ORGANIZATION

     

    New York

     

    NUMBER OF

    SHARES

    BENEFICIALLY OWNED

    BY EACH REPORTING

    PERSON

    WITH

    5

    SOLE VOTING POWER

     

    0

    6

    SHARED VOTING POWER

     

    22,768,785

    7

    SOLE DISPOSITIVE POWER

     

    0

    8

    SHARED DISPOSITIVE POWER

     

    22,768,785

    9

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    22,768,785

     
    10

    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

     

     

    ☐
    11

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     

    12.2%

     
    12

    TYPE OF REPORTING PERSON

     

    OO

     

     

       

     

     

    CUSIP No. 01625V104 SCHEDULE 13G Page 9 of 22

     

     

    1

    NAME OF REPORTING PERSON

     

    Warburg Pincus XII, L.P.

     
    2

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

     

     

    (a)  ☐

    (b)  ☒

    3

    SEC USE ONLY

     

     

     
    4

    CITIZENSHIP OR PLACE OF ORGANIZATION

     

    Delaware

     

    NUMBER OF

    SHARES

    BENEFICIALLY OWNED

    BY EACH REPORTING

    PERSON

    WITH

    5

    SOLE VOTING POWER

     

    0

    6

    SHARED VOTING POWER

     

    22,768,785

    7

    SOLE DISPOSITIVE POWER

     

    0

    8

    SHARED DISPOSITIVE POWER

     

    22,768,785

    9

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    22,768,785

     
    10

    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

     

     

    ☐
    11

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     

    12.2%

     
    12

    TYPE OF REPORTING PERSON

     

    PN

     

     

       

     

     

    CUSIP No. 01625V104 SCHEDULE 13G Page 10 of 22

     

     

    1

    NAME OF REPORTING PERSON

     

    WP Global LLC

     
    2

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

     

     

    (a)  ☐

    (b)  ☒

    3

    SEC USE ONLY

     

     

     
    4

    CITIZENSHIP OR PLACE OF ORGANIZATION

     

    Delaware

     

    NUMBER OF

    SHARES

    BENEFICIALLY OWNED

    BY EACH REPORTING

    PERSON

    WITH

    5

    SOLE VOTING POWER

     

    0

    6

    SHARED VOTING POWER

     

    22,768,785

    7

    SOLE DISPOSITIVE POWER

     

    0

    8

    SHARED DISPOSITIVE POWER

     

    22,768,785

    9

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    22,768,785

     
    10

    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

     

     

    ☐
    11

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     

    12.2%

     
    12

    TYPE OF REPORTING PERSON

     

    OO

     

     

       

     

     

    CUSIP No. 01625V104 SCHEDULE 13G Page 11 of 22

     

     

    1

    NAME OF REPORTING PERSON

     

    Warburg Pincus Partners II, L.P.

     
    2

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

     

     

    (a)  ☐

    (b)  ☒

    3

    SEC USE ONLY

     

     

     
    4

    CITIZENSHIP OR PLACE OF ORGANIZATION

     

    Delaware

     

    NUMBER OF

    SHARES

    BENEFICIALLY OWNED

    BY EACH REPORTING

    PERSON

    WITH

    5

    SOLE VOTING POWER

     

    0

    6

    SHARED VOTING POWER

     

    22,768,785

    7

    SOLE DISPOSITIVE POWER

     

    0

    8

    SHARED DISPOSITIVE POWER

     

    22,768,785

    9

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    22,768,785

     
    10

    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

     

     

    ☐
    11

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     

    12.2%

     
    12

    TYPE OF REPORTING PERSON

     

    PN

     

     

       

     

     

    CUSIP No. 01625V104 SCHEDULE 13G Page 12 of 22

     

     

    1

    NAME OF REPORTING PERSON

     

    Warburg Pincus Partners II Holdings, L.P.

     
    2

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

     

     

    (a)  ☐

    (b)  ☒

    3

    SEC USE ONLY

     

     

     
    4

    CITIZENSHIP OR PLACE OF ORGANIZATION

     

    Delaware

     

    NUMBER OF

    SHARES

    BENEFICIALLY OWNED

    BY EACH REPORTING

    PERSON

    WITH

    5

    SOLE VOTING POWER

     

    0

    6

    SHARED VOTING POWER

     

    22,768,785

    7

    SOLE DISPOSITIVE POWER

     

    0

    8

    SHARED DISPOSITIVE POWER

     

    22,768,785

    9

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    22,768,785

     
    10

    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

     

     

    ☐
    11

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     

    12.2%

     
    12

    TYPE OF REPORTING PERSON

     

    PN

     

     

       

     

     

    CUSIP No. 01625V104 SCHEDULE 13G Page 13 of 22

     

     

    1

    NAME OF REPORTING PERSON

     

    Warburg Pincus Partners GP LLC

     
    2

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

     

     

    (a)  ☐

    (b)  ☒

    3

    SEC USE ONLY

     

     

     
    4

    CITIZENSHIP OR PLACE OF ORGANIZATION

     

    Delaware

     

    NUMBER OF

    SHARES

    BENEFICIALLY OWNED

    BY EACH REPORTING

    PERSON

    WITH

    5

    SOLE VOTING POWER

     

    0

    6

    SHARED VOTING POWER

     

    22,768,785

    7

    SOLE DISPOSITIVE POWER

     

    0

    8

    SHARED DISPOSITIVE POWER

     

    22,768,785

    9

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    22,768,785

     
    10

    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

     

     

    ☐
    11

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     

    12.2%

     
    12

    TYPE OF REPORTING PERSON

     

    OO

     

     

       

     

     

    CUSIP No. 01625V104 SCHEDULE 13G Page 14 of 22

     

     

    1

    NAME OF REPORTING PERSON

     

    Warburg Pincus & Co.

     
    2

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

     

     

    (a)  ☐

    (b)  ☒

    3

    SEC USE ONLY

     

     

     
    4

    CITIZENSHIP OR PLACE OF ORGANIZATION

     

    New York

     

    NUMBER OF

    SHARES

    BENEFICIALLY OWNED

    BY EACH REPORTING

    PERSON

    WITH

    5

    SOLE VOTING POWER

     

    0

    6

    SHARED VOTING POWER

     

    22,768,785

    7

    SOLE DISPOSITIVE POWER

     

    0

    8

    SHARED DISPOSITIVE POWER

     

    22,768,785

    9

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    22,768,785

     
    10

    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

     

     

    ☐
    11

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     

    12.2%

     
    12

    TYPE OF REPORTING PERSON

     

    PN

     

     

       

     

     

    CUSIP No. 01625V104 SCHEDULE 13G Page 15 of 22

     

     

    Item 1(a). Name of Issuer:
       
      Alignment Healthcare, Inc. (the “Company”).
       
    Item 1(b). Address of Issuer’s Principal Executive Offices:
       
      1100 W. Town and Country Road, Suite 1600, Orange, CA 92868.
       
    Item 2(a).

    Name of Person Filing:

       
      This Statement is being filed on behalf of each of the following persons (collectively, the “Warburg Pincus Reporting Persons”):
       
      1. Warburg Pincus Private Equity XII, L.P., a Delaware limited partnership (“WP XII”), owned of record 14,665,604 shares of common stock or 7.8% of the issued and outstanding shares of common stock.
      2. Warburg Pincus Private Equity XII-B, L.P., a Delaware limited partnership (“WP XII-B”), owned of record 2,942,410 shares of common stock or 1.6% of the issued and outstanding shares of common stock.
      3. Warburg Pincus Private Equity XII-D, L.P., a Delaware limited partnership (“WP XII-D”), owned of record 423,271 shares of common stock or 0.2% of the issued and outstanding shares of common stock.
      4. Warburg Pincus Private Equity XII-E, L.P., a Delaware limited partnership (“WP XII-E”), owned of record 2,415,767 shares of common stock or 1.3% of the issued and outstanding shares of common stock.
      5. WP XII Partners, L.P., a Delaware limited partnership (“WP XII Partners”), owned of record 791,215 shares of common stock or 0.4% of the issued and outstanding shares of common stock.
      6. Warburg Pincus XII Partners, L.P., a Delaware limited partnership (“Warburg Pincus XII Partners”, and, together with WP XII, WP XII-B, WP XII-D, WP XII-E and WP XII Partners, the “WP XII Funds”), owned of record 1,530,518 shares of common stock or 0.8% of the issued and outstanding shares of common stock.
      7. Warburg Pincus LLC, a New York limited liability company (“WP LLC”), is the manager of WP XII Funds.
      8. Warburg Pincus XII, L.P., a Delaware limited partnership (“WP XII GP”), is the general partner of the WP XII Funds.
      9. WP Global LLC, a Delaware limited liability company (“WP Global”), is the general partner of WP XII GP.
      10.

    Warburg Pincus Partners II, L.P., a Delaware limited partnership (“WPP II”), is the managing member of WP Global.

      11.

    Warburg Pincus Partners II Holdings, L.P., a Delaware limited partnership (“WPP II Holdings”), is a limited partner of WPP II.

      12.

    Warburg Pincus Partners GP LLC, a Delaware limited liability company (“WPP GP”), is the general partner of WPP II and WPP II Holdings.

      13. Warburg Pincus & Co, a New York general partnership (“WP”), is the managing member of WPP GP.
       
      Investment and voting decisions with respect to the Class A Ordinary Shares of the Company held by the Warburg Pincus Reporting Persons are made by a committee comprised of three or more individuals and all members of such committee disclaim beneficial ownership of the shares held by the Warburg Pincus Reporting Persons.
       
    Item 2(b).

    Address of Principal Business Office or, if none, Residence:

       
     

    For all Warburg Pincus Reporting Persons:

    450 Lexington Avenue, New York, New York 10017, U.S.A.

       
    Item 2(c). Citizenship or Place of Organization:
       
      See Item 2(a).

     

       

     

     

    CUSIP No. 01625V104 SCHEDULE 13G Page 16 of 22

     

     

    Item 2(d). Title of Class of Securities
       
      Common stock, par value $0.001 per share (the “common stock”).
       
    Item 2(e). CUSIP Number:
     
      01625V104.
       
    Item 3. Statement filed pursuant to Rule 13d-1(b), or 13d-2(b) or (c):
       
      Not applicable.
       
    Item 4. Ownership:
       
      The information required by Items 4(a) – (c) is set forth in Rows 5-11 of the cover page for each Reporting Person hereto and is incorporated herein by reference for each Reporting Person.
       
    Item 4. Ownership:
       
     

    The information required by Items 4(a) – (c) is set forth in Rows 5-11 of the cover page for each Reporting Person hereto and is incorporated herein by reference for each Reporting Person.

     

    Warburg Pincus XII, L.P., a Delaware limited partnership ("WP XII GP"), is the general partner of the WP XII Funds. WP Global LLC, a Delaware limited liability company ("WP Global"), is the general partner of WP XII GP. Warburg Pincus Partners II, L.P., a Delaware limited partnership ("WPP II"), is the managing member of WP Global. Warburg Pincus Partners II Holdings, L.P., a Delaware limited partnership ("WPP II Holdings"), is a limited partner of WPP II. Warburg Pincus Partners GP LLC, a Delaware limited liability company ("WPP GP"), is the general partner of WPP II and WPP II Holdings. Warburg Pincus & Co., a New York general partnership ("WP"), is the managing member of WPP GP. Warburg Pincus LLC, a New York limited liability company ("WP LLC") is a registered investment adviser and the manager of the WP XII Funds. Investment and voting decisions with respect to the shares of common stock held by the WP XII Funds are made by a committee comprised of three or more individuals and all members of such committee disclaim beneficial ownership of the shares of common stock.

     

    Percentage Owned:

    All calculations of percentage ownership herein are based on an aggregate of 187,241,668 shares of common stock reported by the Company to be outstanding, as reflected in the Company’s prospectus filed under Rule 424(b)(4) with the U.S. Securities and Exchange Commission on November 19, 2021.

       
    Item 5. Ownership of Five Percent or Less of a Class:
       
      Not applicable.
     
    Item 6. Ownership of More than Five Percent on Behalf of Another Person:
       
      Not applicable.
     
    Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company or Control Person:
       
      Not applicable.

     

       

     

     

    CUSIP No. 01625V104 SCHEDULE 13G Page 17 of 22

     

     

    Item 8. Identification and Classification of Members of the Group:
       
      The Warburg Pincus Reporting Persons are making this single, joint filing because they may be deemed to constitute a “group” within the meaning of Section 13(d)(3) of the Exchange Act. The joint filing agreement among the Warburg Pincus Reporting Persons to file jointly is attached hereto as Exhibit 1.
     
    Item 9. Notice of Dissolution of Group:
       
      Not applicable.
       
    Item 10. Certifications:
       
      Not applicable.

     

       

     

     

    CUSIP No. 01625V104 SCHEDULE 13G Page 18 of 22

     

     

    Exhibit Index

     

    Exhibit No.   Description
    Exhibit 1  

    Joint Filing Agreement as required by Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended.

     

     

     

     

       

     

     

    CUSIP No. 01625V104 SCHEDULE 13G Page 19 of 22

     

     

    SIGNATURE

     

    After reasonable inquiry and to the best of its knowledge and belief, the undersigned certify that the information set forth in this statement is true, complete and correct.

     

    Dated: February 14, 2022

     

      Warburg Pincus Private Equity XII, L.P.  
         
      By: Warburg Pincus XII, L.P., its general partner  
      By: WP Global LLC, its general partner  
      By: Warburg Pincus Partners II, L.P., its managing member  
      By: Warburg Pincus Partners GP LLC, its general partner  
      By: Warburg Pincus & Co., its managing member  
           
      By: /s/ Harsha Marti  
      Name: Harsha Marti  
      Title: Partner  
         
         
      Warburg Pincus Private Equity XII-B, L.P.  
         
      By: Warburg Pincus XII, L.P., its general partner  
      By: WP Global LLC, its general partner  
      By: Warburg Pincus Partners II, L.P., its managing member  
      By: Warburg Pincus Partners GP LLC, its general partner  
      By: Warburg Pincus & Co., its managing member  
           
      By: /s/ Harsha Marti  
      Name: Harsha Marti  
      Title: Partner  
           
           
      Warburg Pincus Private Equity XII-D, L.P.  
         
      By: Warburg Pincus XII, L.P., its general partner  
      By: WP Global LLC, its general partner  
      By: Warburg Pincus Partners II, L.P., its managing member  
      By: Warburg Pincus Partners GP LLC, its general partner  
      By: Warburg Pincus & Co., its managing member  
           
      By: /s/ Harsha Marti  
      Name: Harsha Marti  
      Title: Partner  

     

       

     

     

    CUSIP No. 01625V104 SCHEDULE 13G Page 20 of 22

     

     

      Warburg Pincus Private Equity XII-E, L.P.  
         
      By: Warburg Pincus XII, L.P., its general partner  
      By: WP Global LLC, its general partner  
      By: Warburg Pincus Partners II, L.P., its managing member  
      By: Warburg Pincus Partners GP LLC, its general partner  
      By: Warburg Pincus & Co., its managing member  
           
      By: /s/ Harsha Marti  
      Name: Harsha Marti  
      Title: Partner  
         
         
      WP XII Partners, L.P.  
         
      By: Warburg Pincus XII, L.P., its general partner  
      By: WP Global LLC, its general partner  
      By: Warburg Pincus Partners II, L.P., its managing member  
      By: Warburg Pincus Partners GP LLC, its general partner  
      By: Warburg Pincus & Co., its managing member  
           
      By: /s/ Harsha Marti  
      Name: Harsha Marti  
      Title: Partner  
         
         
      Warburg Pincus XII Partners, L.P.  
         
      By: Warburg Pincus XII, L.P., its general partner  
      By: WP Global LLC, its general partner  
      By: Warburg Pincus Partners II, L.P., its managing member  
      By: Warburg Pincus Partners GP LLC, its general partner  
      By: Warburg Pincus & Co., its managing member  
           
      By: /s/ Harsha Marti  
      Name: Harsha Marti  
      Title: Partner  

     

       

     

     

    CUSIP No. 01625V104 SCHEDULE 13G Page 21 of 22

     

     

      Warburg Pincus LLC  
         
      By: /s/ Harsha Marti  
      Name: Harsha Marti  
      Title: Partner  
         
         
      Warburg Pincus XII, L.P.  
         
      By: WP Global LLC, its general partner  
      By: Warburg Pincus Partners II, L.P., its managing member  
      By: Warburg Pincus Partners GP LLC, its general partner  
      By: Warburg Pincus & Co., its managing member  
           
      By: /s/ Harsha Marti  
      Name: Harsha Marti  
      Title: Partner  
         
         
      WP Global LLC  
         
      By: Warburg Pincus Partners II, L.P., its managing member  
      By: Warburg Pincus Partners GP LLC, its general partner  
      By: Warburg Pincus & Co., its managing member  
           
      By: /s/ Harsha Marti  
      Name: Harsha Marti  
      Title: Partner  
         
         
      Warburg Pincus Partners II, L.P.  
         
      By: Warburg Pincus Partners GP LLC, its general partner  
      By: Warburg Pincus & Co., its managing member  
           
      By: /s/ Harsha Marti  
      Name: Harsha Marti  
      Title: Partner  

     

       

     

     

    CUSIP No. 01625V104 SCHEDULE 13G Page 22 of 22

     

      Warburg Pincus Partners II Holdings, L.P.  
         
      By: Warburg Pincus Partners GP LLC, its general partner  
      By: Warburg Pincus & Co., its managing member  
           
      By: /s/ Harsha Marti  
      Name: Harsha Marti  
      Title: Partner  
           

     

      Warburg Pincus Partners GP LLC  
         
      By: Warburg Pincus & Co., its managing member  
           
      By: /s/ Harsha Marti  
      Name: Harsha Marti  
      Title: Partner  
         
         
      Warburg Pincus & Co.  
         
      By: /s/ Harsha Marti  
      Name: Harsha Marti  
      Title: Partner  

     

       

     

     

    EXHIBIT 1

      

    JOINT ACQUISITION STATEMENT

    PURSUANT TO RULE 13D-1(k)(1)

     

    The undersigned acknowledge and agree that the foregoing statement on Schedule 13G is filed on behalf of each of the undersigned and that all subsequent amendments to this statement on Schedule 13G shall be filed on behalf of each of the undersigned without the necessity of filing additional joint acquisition statements. The undersigned acknowledge that each shall be responsible for the timely filing of such amendments, and for the completeness and accuracy of the information concerning him, her or it contained herein, but shall not be responsible for the completeness and accuracy of the information concerning the other entities or persons, except to the extent that he, she or it knows or has reason to believe that such information is accurate.

     

    Dated: February 14, 2022

     

      Warburg Pincus Private Equity XII, L.P.  
         
      By: Warburg Pincus XII, L.P., its general partner  
      By: WP Global LLC, its general partner  
      By: Warburg Pincus Partners II, L.P., its managing member  
      By: Warburg Pincus Partners GP LLC, its general partner  
      By: Warburg Pincus & Co., its managing member  
           
      By: /s/ Harsha Marti  
      Name: Harsha Marti  
      Title: Partner  
         
         
      Warburg Pincus Private Equity XII-B, L.P.  
         
      By: Warburg Pincus XII, L.P., its general partner  
      By: WP Global LLC, its general partner  
      By: Warburg Pincus Partners II, L.P., its managing member  
      By: Warburg Pincus Partners GP LLC, its general partner  
      By: Warburg Pincus & Co., its managing member  
           
      By: /s/ Harsha Marti  
      Name: Harsha Marti  
      Title: Partner  
           
           
      Warburg Pincus Private Equity XII-D, L.P.  
         
      By: Warburg Pincus XII, L.P., its general partner  
      By: WP Global LLC, its general partner  
      By: Warburg Pincus Partners II, L.P., its managing member  
      By: Warburg Pincus Partners GP LLC, its general partner  
      By: Warburg Pincus & Co., its managing member  
           
      By: /s/ Harsha Marti  
      Name: Harsha Marti  
      Title: Partner  

     

       

     

     

      Warburg Pincus Private Equity XII-E, L.P.  
         
      By: Warburg Pincus XII, L.P., its general partner  
      By: WP Global LLC, its general partner  
      By: Warburg Pincus Partners II, L.P., its managing member  
      By: Warburg Pincus Partners GP LLC, its general partner  
      By: Warburg Pincus & Co., its managing member  
           
      By: /s/ Harsha Marti  
      Name: Harsha Marti  
      Title: Partner  
         
         
      WP XII Partners, L.P.  
         
      By: Warburg Pincus XII, L.P., its general partner  
      By: WP Global LLC, its general partner  
      By: Warburg Pincus Partners II, L.P., its managing member  
      By: Warburg Pincus Partners GP LLC, its general partner  
      By: Warburg Pincus & Co., its managing member  
           
      By: /s/ Harsha Marti  
      Name: Harsha Marti  
      Title: Partner  
         
         
      Warburg Pincus XII Partners, L.P.  
         
      By: Warburg Pincus XII, L.P., its general partner  
      By: WP Global LLC, its general partner  
      By: Warburg Pincus Partners II, L.P., its managing member  
      By: Warburg Pincus Partners GP LLC, its general partner  
      By: Warburg Pincus & Co., its managing member  
           
      By: /s/ Harsha Marti  
      Name: Harsha Marti  
      Title: Partner  

     

       

     

     

      Warburg Pincus LLC  
         
      By: /s/ Harsha Marti  
      Name: Harsha Marti  
      Title: Partner  
         
         
      Warburg Pincus XII, L.P.  
         
      By: WP Global LLC, its general partner  
      By: Warburg Pincus Partners II, L.P., its managing member  
      By: Warburg Pincus Partners GP LLC, its general partner  
      By: Warburg Pincus & Co., its managing member  
           
      By: /s/ Harsha Marti  
      Name: Harsha Marti  
      Title: Partner  
         
         
      WP Global LLC  
         
      By: Warburg Pincus Partners II, L.P., its managing member  
      By: Warburg Pincus Partners GP LLC, its general partner  
      By: Warburg Pincus & Co., its managing member  
           
      By: /s/ Harsha Marti  
      Name: Harsha Marti  
      Title: Partner  
         
         
      Warburg Pincus Partners II, L.P.  
         
      By: Warburg Pincus Partners GP LLC, its general partner  
      By: Warburg Pincus & Co., its managing member  
           
      By: /s/ Harsha Marti  
      Name: Harsha Marti  
      Title: Partner  

     

       

     

     

      Warburg Pincus Partners II Holdings, L.P.  
         
      By: Warburg Pincus Partners GP LLC, its general partner  
      By: Warburg Pincus & Co., its managing member  
           
      By: /s/ Harsha Marti  
      Name: Harsha Marti  
      Title: Partner  

     

     

      Warburg Pincus Partners GP LLC  
         
      By: Warburg Pincus & Co., its managing member  
           
      By: /s/ Harsha Marti  
      Name: Harsha Marti  
      Title: Partner  
         
         
      Warburg Pincus & Co.  
         
      By: /s/ Harsha Marti  
      Name: Harsha Marti  
      Title: Partner  

     

       

     

    Get the next $ALHC alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ALHC

    DatePrice TargetRatingAnalyst
    11/24/2025$20.00Neutral → Overweight
    Analyst
    10/14/2025$21.00Buy
    Goldman
    8/25/2025$21.00Sector Weight → Overweight
    KeyBanc Capital Markets
    7/31/2025$13.00Underweight → Equal Weight
    Barclays
    12/3/2024$13.00 → $17.00Equal-Weight → Overweight
    Stephens
    10/11/2024Sector Weight
    KeyBanc Capital Markets
    5/30/2024$10.00Outperform
    Robert W. Baird
    5/30/2024$7.75 → $11.00Neutral → Buy
    BofA Securities
    More analyst ratings

    $ALHC
    SEC Filings

    View All

    Amendment: SEC Form SCHEDULE 13G/A filed by Alignment Healthcare Inc.

    SCHEDULE 13G/A - Alignment Healthcare, Inc. (0001832466) (Subject)

    2/10/26 11:23:19 AM ET
    $ALHC
    Medical Specialities
    Health Care

    SEC Form SCHEDULE 13G filed by Alignment Healthcare Inc.

    SCHEDULE 13G - Alignment Healthcare, Inc. (0001832466) (Subject)

    2/5/26 1:16:32 PM ET
    $ALHC
    Medical Specialities
    Health Care

    Amendment: SEC Form SCHEDULE 13G/A filed by Alignment Healthcare Inc.

    SCHEDULE 13G/A - Alignment Healthcare, Inc. (0001832466) (Subject)

    1/30/26 1:27:18 PM ET
    $ALHC
    Medical Specialities
    Health Care

    $ALHC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Human Resources Officer Wagner Andreas P. sold $455,212 worth of shares (22,238 units at $20.47), decreasing direct ownership by 12% to 169,805 units (SEC Form 4)

    4 - Alignment Healthcare, Inc. (0001832466) (Issuer)

    2/10/26 9:51:27 PM ET
    $ALHC
    Medical Specialities
    Health Care

    Chief Executive Officer Kao John E sold $3,687,354 worth of shares (180,000 units at $20.49) (SEC Form 4)

    4 - Alignment Healthcare, Inc. (0001832466) (Issuer)

    2/10/26 9:50:30 PM ET
    $ALHC
    Medical Specialities
    Health Care

    SEC Form 3 filed by new insider Mansour Adnan R.

    3 - Alignment Healthcare, Inc. (0001832466) (Issuer)

    1/21/26 4:27:42 PM ET
    $ALHC
    Medical Specialities
    Health Care

    $ALHC
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Alignment Healthcare to Announce Fourth Quarter and Full-Year 2025 Financial Results and Host Conference Call Thursday, Feb. 26, 2026

    ORANGE, Calif., Feb. 05, 2026 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ:ALHC), will release its fourth quarter and full-year 2025 financial results on Thursday, Feb. 26, 2026, after market close. Following the release, the company will host a conference call to review its financial results at 5 p.m. EST. Conference Call DetailsA live audio webcast will be available online at https://ir.alignmenthealth.com/. At the start of the conference call, participants may access the webcast at the following link: https://edge.media-server.com/mmc/p/kd529mia A replay of the call will be available via webcast for on-demand listening shortly after the completion of the call at the same we

    2/5/26 8:00:00 AM ET
    $ALHC
    Medical Specialities
    Health Care

    Alignment Healthcare Named to the 2026 Fortune World's Most Admired Companies™ List for First Time

    ORANGE, Calif., Jan. 21, 2026 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ:ALHC), an award-winning Medicare Advantage (MA) company, has been named to the 2026 Fortune World's Most Admired Companies™ (WMAC) list, debuting in its first year of consideration for this global honor – a peer-rated recognition that affirms the company's reputation and momentum five years after going public. The honor reflects how executives and analysts in the Health Care: Insurance and Managed Care category view Alignment's leadership, innovation and operating ability. To be included, companies must place in the top half of their industry in Fortune's annual reputation survey. "We're incredibly proud

    1/21/26 11:00:00 AM ET
    $ALHC
    Medical Specialities
    Health Care

    Alignment Health Appoints Adnan Mansour as Chief Digital Officer to Accelerate AI-Driven Growth and Technology Leadership

    ORANGE, Calif., Jan. 20, 2026 (GLOBE NEWSWIRE) -- Alignment Health, an award-winning Medicare Advantage (MA) company, today announced the appointment of Adnan Mansour as chief digital officer, an executive leadership role that unifies the company's technology and information functions to drive scalable growth and continued innovation. Mansour, formerly senior vice president and chief information officer at Optum Insight – the data, analytics and managed services division of UnitedHealth Group – brings decades of experience leading global IT and engineering teams and embedding artificial intelligence (AI) into complex health care systems. Effective Jan. 19, Mansour reports to Alignment Hea

    1/20/26 8:00:00 AM ET
    $ALHC
    Medical Specialities
    Health Care

    $ALHC
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Kao John E bought $496,779 worth of shares (103,000 units at $4.82), increasing direct ownership by 4% to 2,745,253 units (SEC Form 4)

    4 - Alignment Healthcare, Inc. (0001832466) (Issuer)

    3/18/24 5:27:36 PM ET
    $ALHC
    Medical Specialities
    Health Care

    $ALHC
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Alignment Healthcare upgraded by Analyst with a new price target

    Analyst upgraded Alignment Healthcare from Neutral to Overweight and set a new price target of $20.00

    11/24/25 8:06:33 AM ET
    $ALHC
    Medical Specialities
    Health Care

    Goldman initiated coverage on Alignment Healthcare with a new price target

    Goldman initiated coverage of Alignment Healthcare with a rating of Buy and set a new price target of $21.00

    10/14/25 8:46:39 AM ET
    $ALHC
    Medical Specialities
    Health Care

    Alignment Healthcare upgraded by KeyBanc Capital Markets with a new price target

    KeyBanc Capital Markets upgraded Alignment Healthcare from Sector Weight to Overweight and set a new price target of $21.00

    8/25/25 8:07:20 AM ET
    $ALHC
    Medical Specialities
    Health Care

    $ALHC
    Leadership Updates

    Live Leadership Updates

    View All

    Alignment Health Appoints Adnan Mansour as Chief Digital Officer to Accelerate AI-Driven Growth and Technology Leadership

    ORANGE, Calif., Jan. 20, 2026 (GLOBE NEWSWIRE) -- Alignment Health, an award-winning Medicare Advantage (MA) company, today announced the appointment of Adnan Mansour as chief digital officer, an executive leadership role that unifies the company's technology and information functions to drive scalable growth and continued innovation. Mansour, formerly senior vice president and chief information officer at Optum Insight – the data, analytics and managed services division of UnitedHealth Group – brings decades of experience leading global IT and engineering teams and embedding artificial intelligence (AI) into complex health care systems. Effective Jan. 19, Mansour reports to Alignment Hea

    1/20/26 8:00:00 AM ET
    $ALHC
    Medical Specialities
    Health Care

    Alignment Healthcare Names Matt Eyles Executive Vice President of Government & Business Strategy

    ORANGE, Calif., Sept. 08, 2025 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ:ALHC) today announced that Matt Eyles will join as executive vice president of government and business strategy, effective Sept. 29. In this newly created position, Eyles will report directly to Alignment founder and CEO John Kao, elevating Alignment's engagement and leadership in health care policy at federal and state levels, leading innovative business planning to anticipate changes in the health care environment to drive growth, and developing new initiatives and partnerships aligned with enterprise priorities. "With Alignment's growing influence and impact, Matt's appointment comes at exactly the ri

    9/8/25 8:00:00 AM ET
    $ALHC
    Medical Specialities
    Health Care

    Alignment Healthcare Founder and CEO John Kao Named to AHIP Board

    ORANGE, Calif., June 10, 2025 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ:ALHC) announced today that founder and CEO John Kao was elected to the AHIP board of directors, effective June 5, 2025. AHIP is a national business organization whose member companies provide health care coverage, services and solutions to millions of Americans every day. "I'm honored to join the AHIP board and collaborate with leaders across the industry who are committed to making health care work better for more Americans," said Kao. "The industry is at a critical inflection point, and I look forward to working with my fellow board members to help shape a stronger, more sustainable future for everyone

    6/10/25 8:00:00 AM ET
    $ALHC
    Medical Specialities
    Health Care

    $ALHC
    Financials

    Live finance-specific insights

    View All

    Alignment Healthcare to Announce Fourth Quarter and Full-Year 2025 Financial Results and Host Conference Call Thursday, Feb. 26, 2026

    ORANGE, Calif., Feb. 05, 2026 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ:ALHC), will release its fourth quarter and full-year 2025 financial results on Thursday, Feb. 26, 2026, after market close. Following the release, the company will host a conference call to review its financial results at 5 p.m. EST. Conference Call DetailsA live audio webcast will be available online at https://ir.alignmenthealth.com/. At the start of the conference call, participants may access the webcast at the following link: https://edge.media-server.com/mmc/p/kd529mia A replay of the call will be available via webcast for on-demand listening shortly after the completion of the call at the same we

    2/5/26 8:00:00 AM ET
    $ALHC
    Medical Specialities
    Health Care

    Alignment Healthcare Reports Third Quarter 2025 Results, Surpasses High-End of Guidance Across All Key Metrics

    Reports Q3 revenue of $993.7 million, up 43.5% year-over-yearBeats high end of third quarter guidance and raises full-year outlook across all key metrics: membership, revenue, adjusted gross profit and adjusted EBITDAHas 100% of members in plans rated 4 stars or higher for second consecutive year in 2026, including two 5-star contracts in Nevada and North Carolina and a 4.5-star contract in Texas ORANGE, Calif., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ:ALHC), today reported financial results for its third quarter ended September 30, 2025. "Our third quarter results mark the third consecutive quarter in which we surpassed the high end of our guidance across all

    10/30/25 4:01:00 PM ET
    $ALHC
    Medical Specialities
    Health Care

    Alignment Healthcare to Announce Third Quarter 2025 Financial Results and Host Conference Call Thursday, Oct. 30, 2025

    ORANGE, Calif., Oct. 02, 2025 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ:ALHC), will release its third quarter 2025 financial results on Thursday, Oct. 30, 2025, after market close. Following the release, the company will host a conference call to review its financial results at 5 p.m. EDT. Conference Call DetailsA live audio webcast will be available online at https://ir.alignmenthealth.com. At the start of the conference call, participants may access the webcast at the following link: https://edge.media-server.com/mmc/p/ov96m6yi A replay of the call will be available via webcast for on-demand listening shortly after the completion of the call at the same web links and will

    10/2/25 8:00:00 AM ET
    $ALHC
    Medical Specialities
    Health Care

    $ALHC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Alignment Healthcare Inc.

    SC 13G/A - Alignment Healthcare, Inc. (0001832466) (Subject)

    11/14/24 5:57:27 PM ET
    $ALHC
    Medical Specialities
    Health Care

    Amendment: SEC Form SC 13G/A filed by Alignment Healthcare Inc.

    SC 13G/A - Alignment Healthcare, Inc. (0001832466) (Subject)

    11/14/24 1:28:35 PM ET
    $ALHC
    Medical Specialities
    Health Care

    Amendment: SEC Form SC 13G/A filed by Alignment Healthcare Inc.

    SC 13G/A - Alignment Healthcare, Inc. (0001832466) (Subject)

    11/12/24 1:26:14 PM ET
    $ALHC
    Medical Specialities
    Health Care